'); } -->
DURHAM -- Kenneth West and his colleagues do a lot of hand-holding on the job.
The five executives make up Technology Commercialization Group, and they make their living by helping foreign companies move into North Carolina.
Such work is left to the state's Department of Commerce and various economic groups, but the reality is that those groups go after large companies with big budgets and work forces.
FOUNDED: 1988
BUSINESS: Products for dental surgery
HOME: Kleinostheim, Germany
EMPLOYEES: About 80, including 10 in Durham
CEO: Hans Dieter Rossler
REVENUE: About $19 million projected in 2007
KENNETH WEST, 51
Moved to the Triangle about 20 years ago from Philadelphia, where he worked for FMC Corp., an international chemical company. Joined Embrex, a Raleigh biotech company that spun out of N.C. State University, as vice president of marketing and business development. Co-founded Biolex, an NCSU biotech spinoff in Pittsboro, about 10 years ago.
DENNIS BURNS, 62
Former Johnson & Johnson executive who in the early 1990s became chief executive of Macronex, a Duke University biotech spinoff in Morrisville that received funding from Durham venture capital firm Intersouth Partners.
ROBERT KEEFER, 64
Former SmithKline Beecham executive who moved to the Triangle from San Diego about five years ago to join a Research Triangle Park chemical research institute, now known as the Hamner Institute, as vice president of business development.
JIM SHELDON, 60
A lawyer and adjunct professor at Duke's Fuqua School of Business, he was one of 24 founding members of the Triangle Council for Entrepreneurial Development in the mid-1980s. Co-founder of Embrex.
PAUL WAUGAMAN, 68
Former program manager at the National Institutes of Health, he headed the technology licensing programs at the Wake Forest University School of Medicine and NCSU in the 1980s and 1990s.
The companies that TCG helps are small: Most employ fewer than 100 workers. And the idea of dealing with American culture, American regulators and American business practices is daunting for them.
"The U.S. market is very big, very enticing but also very scary," West said.
West and his partners help those businesses navigate the red tape and cultural differences, bringing their experience working with local biotech companies to bear. Companies that hire TCG get services that include help with writing a business plan, establishing a marketing strategy and negotiating packaging information with the Food and Drug Administration.
West started the business about nine years ago with Jim Sheldon and Paul Waugaman, acquaintances from his days at Biolex, an NCSU biotech spinoff in Pittsboro. They had gotten to know one another by negotiating deals. The three were later joined by Dennis Burns and Bob Keefer, who were also part of the Triangle's biotech research and development community.
The five have focused so far on German companies that want to enter the $80 billion U.S. medical-device market.
A medical-device powerhouse long known for cutting-edge technology, Germany is home to more than 1,000 companies making anything from surgical equipment to prostheses. So far, TCG has brought one company to Durham and expects to bring in two others, possibly as soon as this year.
The N.C. Department of Commerce has an office in Frankfurt, but services offered to small and midsize companies overseas are limited to a referral service and a small-business ombudsman.
"We do have some people providing services," said Kathy Neal, a Commerce spokeswoman. "But are we going to provide legal counsel for your incorporation or set up the books for you? No. That's why you have consultants like TCG."
Avoiding missteps in N.C.
West and his partners have lived and worked overseas and are comfortable navigating the bureaucracies and business etiquette of multiple countries. They can guide their clients to avoid misunderstandings and missteps in the United States, where they have experience negotiating patent protection, regulatory approval, product marketing and business development.
Aside from language difficulties, differences in product marketing can spoil the efforts of foreign companies to crack the U.S. market.
In Europe, marketing brochures sell medical devices by providing elaborate descriptions, West said. In the U.S., marketing is all about the benefits of a device. So West, whose mother is French and who as a child spent many summers with relatives in Europe, often finds himself telling clients: "It's the American style, it's not being brash," he said.
Burns, a former Johnson & Johnson executive, has found himself in similar situations since joining TCG.
Different way of operating
In Europe, academics have a lot more stature than in the United States, Burns said. European physicians are much more likely to accept recommendations from well-known academics about a new device. "Here in the U.S., doctors want to see data, he said. "They say, 'Show me a picture.' "
A European company trying to promote its products at a medical conference is likely to watch its written, expert recommendations land in trash cans, Burns said. That doesn't sit well with the European client and frequently requires diplomacy.
Get it all with convenient home delivery of The News & Observer.
The News & Observer is pleased to be able to offer its users the opportunity to make comments and hold conversations online. However, the interactive nature of the internet makes it impracticable for our staff to monitor each and every posting.
Since The News & Observer does not control user submitted statements, we cannot promise that readers will not occasionally find offensive or inaccurate comments posted on our website. In addition, we remind anyone interested in making an online comment that responsibility for statements posted lies with the person submitting the comment, not The News and Observer.
If you find a comment offensive, clicking on the exclamation icon will flag the comment for review by the administrators, we are counting on the good judgment of all our readers to help us.